SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles sharp selloff and reversal of gains after an upbeat investor-day outlook dominate discussion, with traders questioning whether its AI backlog can justify heavy spending and debt before cash flow improves. Some see the funding and cash-flow plan as reassurance, while others blame broader tech weakness and reaction to Google and Amazon results for renewed selling.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs upcoming Q3 report is the main focus, with traders debating whether strong results and higher guidance can clear an elevated bar as AI stocks face pressure. Bulls expect continued growth in its AI business, while bears argue that even a beat may not justify the valuation and could prompt further selling.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTXs breakout to a fresh 52-week high has traders focused on the upcoming Q3 results and BRIUMVIs growth, with the subcutaneous BRIUMVI readout also viewed as a potential catalyst. Heavy call activity and high short interest are fueling squeeze and buyout speculation, though the community disagrees on whether the rally reflects positioning around company fundamentals or an unconfirmed deal rumor.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,251,440,068.9505 in circulation. The last known price of Stellar is 0.16728777 USD and is down -1.15 over the last 24 hours. It is currently trading on 848 active market(s) with $82,083,533.38 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLM is drawing attention for persistent selling and weak price action, with traders saying it struggles to hold key levels and underperforms despite institutional-adoption headlines. The debate centers on whether DTCC and real-world-asset tokenization developments will eventually support the token, while skeptics argue that low fees and token economics may limit any price impact; some also allege ongoing SDF selling.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforces planned acquisition of Braze has drawn attention, with traders weighing the strategic boost to its AI-powered marketing and customer-engagement offerings against concerns about the deals price and integration risks. The discussion also reflects broader debate over whether AI will strengthen or disrupt established software platforms.

Pepe (PEPE) is a cryptocurrency launched in 2023and operates on the Ethereum platform. Pepe has a current supply of 413,772,350,098,130.40630647. The last known price of Pepe is 0.00000489 USD and is down -3.02 over the last 24 hours. It is currently trading on 729 active market(s) with $389,285,493.23 traded over the last 24 hours. More information can be found at https://www.pepe.vip/.

Pepe

PEPE is drawing attention for volatile, largely range-bound trading, with traders watching repeated tests of resistance and debating whether rebounds signal a breakout or another short-lived pump. Dip-buying and accumulation calls contrast with concerns about continued declines, pump-and-dump behavior, and moves tracking broader crypto-market weakness.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens Phase 3 lung-cancer data for IMDELLTRA with AstraZenecas IMFINZI, showing a lower risk of death in extensive-stage small-cell lung cancer, is driving attention. Traders view the result as a promising oncology growth catalyst, alongside discussion of Repathas growth and Amgens upcoming earnings.

Hyperliquid (HYPE) is a cryptocurrency and operates on the Hyperliquid platform. Hyperliquid has a current supply of 950,394,442.10256707 with 253,500,314.85654783 in circulation. The last known price of Hyperliquid is 87.94735104 USD and is down -0.18 over the last 24 hours. It is currently trading on 350 active market(s) with $1,050,863,479.79 traded over the last 24 hours. More information can be found at https://hyperliquid.xyz/.

Hype

Hyperliquids HYPE is drawing attention for its strong rally toward record highs, with traders focused on revenue-funded token buybacks and burns and growing institutional access to its trading platform. Bullish calls about the protocols growth and token demand are tempered by concerns about volatility, pullbacks, and profit-taking.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

Liquidias settlement with United Therapeutics resolved all six lawsuits, keeping Yutrepia available for PAH while giving up the PH-ILD indication and requiring substantial payments. Traders welcomed the reduced legal uncertainty and speculated about a short squeeze, while others focused on the lost market opportunity and financial burden.

Astera Labs, Inc. provides rack-scale AI infrastructure through purpose-built connectivity solutions. The company offers a range of semiconductor-based connectivity solutions designed to address bandwidth, latency, and reliability challenges in AI and cloud data centers. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is facing a sharp pullback as traders debate its high valuation and broader weakness in AI and semiconductor stocks, with upcoming earnings and guidance viewed as a test of demand for its data-center connectivity products. Some see the decline as a buying opportunity tied to continued AI infrastructure spending, while others expect further downside or a post-earnings selloff.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

FMC (FMC) Q3 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

FMC Q3 Earnings Miss on Channel Pricing Actions, Sales Beat

FMC's Q3 loss widens as pricing actions and weak demand hit sales. Despite a revenue beat, the company lowered its 2026 outlook.

FMC Q3 2026 Earnings Call Transcript

FMC (NYSE:FMC) reported third-quarter financial results on Friday. The transcript from the company's third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For real-timeread more...

FMC (FMC) Reports Q3 Loss, Beats Revenue Estimates

FMC (FMC) delivered earnings and revenue surprises of -5,612.50% and +9.29%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook

FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter Outlook FMC Corporation Reports Third-Quarter 2026 Results and Revised Fourth-Quarter OutlookPR NewswirePHILADELPHIA, Oct. 29, 2026 Company provides additional detail on financial impact of previously announced commercial...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMC

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMCPR NewswireNEW YORK, Oct. 29, 2026 NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is...

Archer Daniels Midland (ADM) Reports Next Week: Wall Street Expects Earnings Growth

ADM (ADM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FMC Corporation (FMC) Securities Investigation Notice - Levi & Korsinsky

FMC Corporation (FMC) Securities Investigation Notice - Levi & Korsinsky FMC Corporation (FMC) Securities Investigation Notice - Levi & KorsinskyPR NewswireNEW YORK, Oct. 23, 2026 FMC shareholders suffered a roughly 31%46% share-price decline after the Company slashed its Q3 2026 revenue outlook by...

Lost Money on FMC Corporation Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 30.53% Stock Decline

FMC Corporation ("FMC" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in FMC Corporation (NYSE: FMC), examining whether the Company may...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of FMC Corporation - FMCPR NewswireNEW YORK, Oct. 22, 2026 NEW YORK, Oct. 22, 2026 /PRNewswire/ -- Pomerantz LLP is...

• Reported GAAP EPS of -$4.41 down -595.51% YoY
• Reported revenue of $105.9M down -88.98% YoY
• FMC lowered Q4 revenue excluding India to $1.04B and Adjusted EBITDA to $210M; adjusted EPS was lowered to $0.56$0.70, and full-year free cash flow is expected at -$350M to -$150M.

FMC cited weaker-than-expected demand, revenue excluding India and commercial actions declined 22 percent, commercial actions reduced revenue and Adjusted EBITDA, and full-year outlook includes negative Adjusted EBITDA and free cash flow.

FMC expects the pricing model to reduce rebate volatility, forecasts Q4 volume growth from direct-to-grower sales and new products, and reported a $214M free cash flow improvement, mainly due to favorable working capital dynamics.

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, agriculture, pest control, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Corp.

FMC Stock Crashes 33% On Massive Earnings Downgrade – Citi expects ‘Modest Negative Reaction’ For Peer Corteva

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>The company also expects an adjusted EBITDA loss of $510 million to $565 million in Q3, compared to its earlier forecast of a $120 million to $140 million profit.</li><li>Citi said FMC’s path to being free cash flow positive is ‘increasingly uncertain.’</li><li>RBC Capital said FMC’s full-year 2026 targets are at risk.</li></ul>Shares of FMC Corporation (FMC) tumbled more than 33% on Thursday after the agricultural chemicals maker significantly cut its third-quarter earnings outlook amid inventory pressure and competition from cheaper generic products.The update also raised concerns about peer Corteva (CTVA), with Citi expecting some negative fallout for the stock, although it sees Corteva as less exposed to generic competition.CTVA shares were down more than 4% at the time of writing.<h2 class="st-heading-2">FMC Slashes Revenue, Swings To Massive Loss</h2>FMC now expects third-quarter (Q3) revenue between $65 million and $125 million, compared with its previous forecast of $840 million to $900 million, excluding India. The company also expects an adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) loss of $510 million to $565 million, compared to its earlier forecast of a $120 million to $140 million profit.FMC said the forecast includes an estimated impact of $625 million to $675 million from lowering prices on select products in key markets and modifying its selling and pricing model in the United States.<h2 class="st-heading-2">FMC’s Inventory Issues In Focus</h2>FMC is facing slower-than-expected demand in key markets while distributors are holding higher-priced FMC products. The inventory was purchased under different cost structures and competitive conditions, the company said.&nbsp;&nbsp;Rapid market price declines, driven in part by increased generic competition, have widened the valuation gap between the affected inventory and current market prices, making it difficult to sell the inventory.FMC is considering two steps to address the bottleneck. The company is taking “comprehensive commercial actions” in Brazil, Argentina, the United States and Canada to lower the price of select products. It will also change its selling and pricing model in the United States.The company expects to discuss potential changes to its debt agreements with lenders and provide an updated outlook when it reports earnings on October 29.<h2 class="st-heading-2">Citi Says Corteva Not As Exposed To Generic Pressure</h2>Citi said that while FMC’s actions could improve competitiveness, it sees “a challenging picture for the balance sheet into 2027,” with FMC’s path to free cash flow positivity “increasingly uncertain.”The firm expects a sharp negative reaction in <a class="mention" data-mention="$FMC" data-symbol-id="FMC" href="https://stocktwits.com/symbol/FMC" target="_blank">FMC shares</a> but “a modest negative reaction” in Corteva shares, saying Corteva’s exposure to generic pressure is modest by comparison.RBC Capital added that the change in Q3 outlook puts FMC’s full-year 2026 targets at risk and is likely adding pressure on Corteva’s stock.Earlier this month, Corteva <a href="https://stocktwits.com/news-articles/markets/equity/corteva-s-market-cap-tumbles-by-over-42-b-today-ctva-stock-hits-record-low/cZD0InXRBiz">completed</a> the spin-off of its seed business, Vylor (VYLR), with the company completely focused on crop protection. Corteva is targeting $8.4 billion to $8.7 billion in annual sales by 2029.<h2 class="st-heading-2">Retail's Take</h2>Despite the crash, retail sentiment on Stocktwits surrounding FMC turned ‘bullish’ from ‘neutral’ a day earlier, amid a 300% jump in message volumes.<img src="https://news.stocktwits-cdn.com/FMC_1370c05828.png" alt="FMC.png">One user said that while FMC’s actions could help the company survive bankruptcy, it would not become a $20 stock again.&nbsp;<stembedurl>https://stocktwits.com/ParkerTrades3393/message/666601503</stembedurl>FMC shares are down 62% so far in 2026.Also read:<a href="https://stocktwits.com/news-articles/markets/equity/spacex-united-airlines-after-aal-rollout-starlink/cZxWys7RBrb">&nbsp;SpaceX Expands Footprint With United Airlines Days After AAL Rollout – Starlink’s Now Available On Nearly Half Its Flights</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the FMC Corporation logo is seen displayed on a smartphone screen. 

FMC expects Q3 revenue between $65 million and $125 million, compared with its previous forecast of $840 million to $900 million, excluding India.

Corteva Inc

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$0.76	--	--	N/A
Q3 '26	$0.07	-$4.41	-6875.75%	MISSED
Q2 '26	$0.22	$0.26	18.02%	BEAT
Q1 '26	-$0.38	-$0.23	39.79%	BEAT
Q4 '25	$1.20	$1.20	0.32%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

FMC Earnings

Latest Earnings Results: Q3 '26

Historical Earnings